Report of the EORTC-PAMM Meeting, Brussels, 16-18 March 2009: new strategies for a targeted and personalised therapy of cancer.
作者信息
Camporesi S
机构信息
European School of Molecular Medicine, Via Adamello, 16-20139 Milan, Italy.
出版信息
Ecancermedicalscience. 2009;3:141. doi: 10.3332/ecancer.2009.141. Epub 2009 Apr 2.
Abstract
摘要
相似文献
1
Report of the EORTC-PAMM Meeting, Brussels, 16-18 March 2009: new strategies for a targeted and personalised therapy of cancer.欧洲癌症研究与治疗组织-个性化分子医学会议报告，布鲁塞尔，2009年3月16 - 18日：癌症靶向及个性化治疗的新策略
Ecancermedicalscience. 2009;3:141. doi: 10.3332/ecancer.2009.141. Epub 2009 Apr 2.
2
Report of the EORTC Laboratory Research Division (LDR) Meeting: March 18, 2009, Brussels, Belgium.欧洲癌症研究与治疗组织（EORTC）实验室研究部（LDR）会议报告：2009年3月18日，比利时布鲁塞尔。
Breast Care (Basel). 2009;4(4):273-274. doi: 10.1159/000237147.
3
2007 EORTC-NCI-ASCO annual meeting: molecular markers in cancer.2007年欧洲癌症研究与治疗组织-美国国立癌症研究所-美国临床肿瘤学会年会：癌症中的分子标志物
Ecancermedicalscience. 2008;2:75. doi: 10.3332/eCMS.2008.75. Epub 2008 Feb 18.
4
EORTC-PAMM Group--24th Winter Meeting. 5-8 February 2003, Florence, Italy.
IDrugs. 2003 Apr;6(4):290-3.
5
Is There Any Room for Pharmacometrics With Immuno-Oncology Drugs? Input from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology.免疫肿瘤药物的药物代谢动力学还有发展空间吗？来自 EORTC-PAMM 临床前和早期临床药理学课程的观点。
Anticancer Res. 2019 Jul;39(7):3419-3422. doi: 10.21873/anticanres.13486.
6
The NCI-EORTC Symposia on New Drugs in Cancer Therapy: A Brief History.
Oncologist. 1998;3(4):269-270.
7
Abstracts of the 3rd EORTC-NCI International Meeting on Cancer Molecular Markers. April 18-20, 2004, Brussels, Belgium.
Int J Biol Markers. 2004 Jan-Mar;19 Suppl 3:S7-59.
8
From 'Targeted Therapy' to Targeted Therapy.从“靶向治疗”到靶向治疗。
Anticancer Res. 2019 Jul;39(7):3341-3345. doi: 10.21873/anticanres.13476.
9
A short report: PAMM, a novel antioxidant protein, induced by oxidative stress.简短报告：PAMM，一种新型抗氧化蛋白，由氧化应激诱导产生。
Redox Biol. 2015 Dec;6:446-453. doi: 10.1016/j.redox.2015.09.008. Epub 2015 Sep 23.
10
ESTRO-EORTC meeting on Radiation for Benign Disease: Current Status and Possible Perspectives. Brussels, Belgium, 10-13 October 1999. Abstracts.
Radiother Oncol. 1999 Oct;53 Suppl 1:S1-37.
本文引用的文献
1
Therapeutic opportunities for counteracting apoptosis resistance in childhood leukaemia.克服儿童白血病细胞凋亡抗性的治疗机会。
Br J Haematol. 2009 May;145(4):441-54. doi: 10.1111/j.1365-2141.2009.07603.x.
2
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells.体内免疫诱导的上皮-间质转化产生乳腺癌干细胞。
Cancer Res. 2009 Apr 1;69(7):2887-95. doi: 10.1158/0008-5472.CAN-08-3343. Epub 2009 Mar 10.
3
Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.小分子XIAP抑制剂在胰腺癌临床前模型中增强TRAIL诱导的细胞凋亡和抗肿瘤活性。
Cancer Res. 2009 Mar 15;69(6):2425-34. doi: 10.1158/0008-5472.CAN-08-2436. Epub 2009 Mar 3.
4
The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies.上皮-间质转化与癌症干细胞：对抗癌症治疗的联盟
J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):29-43. doi: 10.1007/s10911-009-9110-3. Epub 2009 Feb 26.
5
Methylated genes as new cancer biomarkers.甲基化基因作为新型癌症生物标志物。
Eur J Cancer. 2009 Feb;45(3):335-46. doi: 10.1016/j.ejca.2008.12.008. Epub 2009 Jan 12.
6
Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.抗上皮细胞粘附分子抗体与循环中正常样乳腺肿瘤细胞的检测
J Natl Cancer Inst. 2009 Jan 7;101(1):61-6. doi: 10.1093/jnci/djn419. Epub 2008 Dec 30.
7
Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Oncology Group Study (S0339).硼替佐米联合吉西他滨/卡铂作为晚期非小细胞肺癌的一线治疗：西南肿瘤协作组II期研究（S0339）
J Thorac Oncol. 2009 Jan;4(1):87-92. doi: 10.1097/JTO.0b013e3181915052.
8
Immunomagnetic detection of micrometastatic cells in bone marrow in uveal melanoma patients.免疫磁珠法检测葡萄膜黑色素瘤患者骨髓微小转移细胞
Acta Ophthalmol. 2009 Nov;87(8):830-6. doi: 10.1111/j.1755-3768.2008.01378.x.
9
Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin.Survivin小分子抑制剂YM155的I期及药代动力学研究
J Clin Oncol. 2008 Nov 10;26(32):5198-203. doi: 10.1200/JCO.2008.17.2064. Epub 2008 Sep 29.
10
Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity.结肠癌干细胞的单细胞克隆揭示了其多谱系分化能力。
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13427-32. doi: 10.1073/pnas.0805706105. Epub 2008 Sep 2.
Zotero 插件